Member Info for Time2Buy

At 11.69

http://www.iii.co.uk/articles/articledisplay.jsp?article_id=1865039&section=Markets

Thanks to Daz Daz - 1 Apr'10 - 10:27 - 1094 of 1094 This does look a potential bagger or more at these levels on the big assumption that trading holds up and the banks aren't too greedy. With 38.35m shares in issue, at a price of 11.5, the mkt cap is 4.29m. Revenues for the full year to 2008 were 137m. So even allowing for a substantial fall for y/e 2009 and that a lot of the revenue is very low margin, the price to sales ratio (PSR) makes the company look very good value. Profits in 2008 (probably a peak year) were £8m, so even a 100% dilution would mean the company values on a p/e of just over 1 on 2008 profits, so even if profits forecasts are halved for 2011, it still means a valuation of 2 on 100% dilution There are still risks as to the terms of the re-financing and the prospects for the education division, given the imminent Government spending cuts but the current price I think discounts all of that and a lot more. Looks good for a further rise even after the mark up so far today, when people start to do the sums.

Would have thought this news may have helped STY but that is still heading down.

Keep a good share down

Now 11p and on that news presents the case as a great buying opportunity. It can also be ISA'd which is good news.

Plenty of upside

Buy at the bottom

With new buyers and shorts clsoing this could be a double bagger.

The continuation of the uptrend continues.

Looks pretty good with bank facilities in place and order intake up.

Tempting

News on their site http://www.tseconsulting.com/

Mmmmm

what he does http://www.growthcompany.co.uk/news/5011/murray-shadowed-by-gyllenhammar.thtml

Good time to pick up on the uptrend

Another point to consider is that the company is loss-making, although it has £45.1m of cash in the bank. Mr Edwards believes this funding will be sufficient to get these two treatments to the end of their trials. Analysts have been slashing their price targets. KBC Peel Hunt cut its target to 33p, which seems a little generous. Piper Jaffray has a 15p target and Nomura Code is targeting 12p. However, investor confidence has been shaken and the results of the phase III trials of AS1413 will not be released until the end of this year.

This Guys track record is pretty good. Nice to have him in the stock.

Just how I like my shares.

Is this worth a trade following such a dramatic fall?